User profiles for David R. Martinez

David R. Martinez, Ph.D.

Assistant Professor of Immunobiology, Yale University School of Medicine
Verified email at yale.edu
Cited by 17554

[PDF][PDF] SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract

…, A Markmann, L Bartelt, R Zumwalt, FJ Martinez… - Cell, 2020 - cell.com
The mode of acquisition and causes for the variable clinical spectrum of coronavirus disease
2019 (COVID-19) remain unknown. We utilized a reverse genetics system to generate a …

[HTML][HTML] SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

…, CA Shaw, A Woods, EJ Fritch, DR Martinez… - Nature, 2020 - nature.com
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to
control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have …

[HTML][HTML] Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

…, LH Tostanoski, X He, DR Martinez, L Rutten, R Bos… - Nature, 2020 - nature.com
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

…, JP Nkolola, J Liu, Z Li, A Chandrashekar, DR Martinez… - Science, 2020 - science.org
The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …

[HTML][HTML] Potently neutralizing and protective human antibodies against SARS-CoV-2

…, RS Nargi, RE Sutton, N Suryadevara, DR Martinez… - Nature, 2020 - nature.com
The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health …

The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

…, R Jadi, DR Martinez, R Raut… - Science …, 2020 - science.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in
late 2019 is responsible for a pandemic of severe respiratory illness. People infected with this …

[HTML][HTML] Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults

…, MS Suthar, DR Martinez, R Baric… - … England Journal of …, 2020 - Mass Medical Soc
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

…, SE Larsen, KM Neuzil, LC Lindesmith, DR Martinez… - Science, 2021 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations may diminish
vaccine-induced protective immune responses, particularly as antibody titers wane over time. …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

…, SJ Berens, RS Baric, DR Martinez… - Science translational …, 2021 - science.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health threat
for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies …

[HTML][HTML] Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

…, BM Nagata, H Andersen, DR Martinez… - … England Journal of …, 2020 - Mass Medical Soc
Background Vaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed.
The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on …